FASTinov, the global leader in rapid Antimicrobial Susceptibility Testing (AST), is proud to announce its participation in the upcoming 34th Edition of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), from 27 to 30 of April in Barcelona, Spain.
Read More...FASTinov proudly announces its recent participation alongside Quilaban at the XIII edition of the esteemed Portuguese National Clinical Pathology Congress.
Read More...FASTinov and Quilaban are thrilled to announce the formal launch of the distribution of FASTinov's cutting-edge products through Quilaban.
Read More...FASTinov announces the appointment of Mr. George Skinner as Director of Commercial Operations of FASTinov.
Read More...FASTinov announces that the prestigious oncology hospital IPO Porto has chosen to introduce its cutting-edge AST technology into its healthcare infrastructure.
Read More...FASTinov announces the publication of groundbreaking data from the very first customer evaluations of its FASTinov® technology.
Read More...
© 2022 FASTinov S.A. - All Rights Reserved - Webdesign by Nova Agência